208 related articles for article (PubMed ID: 31766351)
21. B and T cell prolymphocytic leukaemia.
Cross M; Dearden C
Best Pract Res Clin Haematol; 2019 Sep; 32(3):217-228. PubMed ID: 31585622
[TBL] [Abstract][Full Text] [Related]
22.
Andersson EI; Brück O; Braun T; Mannisto S; Saikko L; Lagström S; Ellonen P; Leppä S; Herling M; Kovanen PE; Mustjoki S
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32188095
[TBL] [Abstract][Full Text] [Related]
23. Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia.
Bergmann AK; Schneppenheim S; Seifert M; Betts MJ; Haake A; Lopez C; Maria Murga Penas E; Vater I; Jayne S; Dyer MJ; Schrappe M; Dührsen U; Ammerpohl O; Russell RB; Küppers R; Dürig J; Siebert R
Genes Chromosomes Cancer; 2014 Apr; 53(4):309-16. PubMed ID: 24446122
[TBL] [Abstract][Full Text] [Related]
24. Deregulation of the Interleukin-7 Signaling Pathway in Lymphoid Malignancies.
Lodewijckx I; Cools J
Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34066732
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells.
Cheng J; Zhang D; Zhou C; Marasco WA
Leuk Res; 2004 Jan; 28(1):71-82. PubMed ID: 14630083
[TBL] [Abstract][Full Text] [Related]
26. Advances in the understanding and management of T-cell prolymphocytic leukemia.
Laribi K; Lemaire P; Sandrini J; Baugier de Materre A
Oncotarget; 2017 Nov; 8(61):104664-104686. PubMed ID: 29262669
[TBL] [Abstract][Full Text] [Related]
27. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
[TBL] [Abstract][Full Text] [Related]
28. Differentially expressed JAK-STAT signaling pathway genes and target microRNAs in the spleen of necrotic enteritis-afflicted chicken lines.
Truong AD; Rengaraj D; Hong Y; Hoang CT; Hong YH; Lillehoj HS
Res Vet Sci; 2017 Dec; 115():235-243. PubMed ID: 28525837
[TBL] [Abstract][Full Text] [Related]
29. Canonical and non-canonical JAK/STAT transcriptional targets may be involved in distinct and overlapping cellular processes.
Tsurumi A; Zhao C; Li WX
BMC Genomics; 2017 Sep; 18(1):718. PubMed ID: 28893190
[TBL] [Abstract][Full Text] [Related]
30. Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia.
Huang L; Liu D; Wang N; Ling S; Tang Y; Wu J; Hao L; Luo H; Hu X; Sheng L; Zhu L; Wang D; Luo Y; Shang Z; Xiao M; Mao X; Zhou K; Cao L; Dong L; Zheng X; Sui P; He J; Mo S; Yan J; Ao Q; Qiu L; Zhou H; Liu Q; Zhang H; Li J; Jin J; Fu L; Zhao W; Chen J; Du X; Qing G; Liu H; Liu X; Huang G; Ma D; Zhou J; Wang QF
Cell Res; 2018 Feb; 28(2):172-186. PubMed ID: 29148541
[TBL] [Abstract][Full Text] [Related]
31. Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent.
Alunno A; Padjen I; Fanouriakis A; Boumpas DT
Cells; 2019 Aug; 8(8):. PubMed ID: 31443172
[TBL] [Abstract][Full Text] [Related]
32. Mining for JAK-STAT mutations in cancer.
Constantinescu SN; Girardot M; Pecquet C
Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
[TBL] [Abstract][Full Text] [Related]
33. HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development.
de Bock CE; Demeyer S; Degryse S; Verbeke D; Sweron B; Gielen O; Vandepoel R; Vicente C; Vanden Bempt M; Dagklis A; Geerdens E; Bornschein S; Gijsbers R; Soulier J; Meijerink JP; Heinäniemi M; Teppo S; Bouvy-Liivrand M; Lohi O; Radaelli E; Cools J
Cancer Discov; 2018 May; 8(5):616-631. PubMed ID: 29496663
[TBL] [Abstract][Full Text] [Related]
34.
Grabarek BO; Wcisło-Dziadecka D; Gola J
Postepy Dermatol Alergol; 2020 Aug; 37(4):513-519. PubMed ID: 32994772
[TBL] [Abstract][Full Text] [Related]
35. [Research Advances of Genetics, Diagnosis and Treatment of T-cell Prolymphocytic Leukemia--Review].
Lai MF; Li F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1977-1981. PubMed ID: 34893145
[TBL] [Abstract][Full Text] [Related]
36. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
Pikman Y; Lee BH; Mercher T; McDowell E; Ebert BL; Gozo M; Cuker A; Wernig G; Moore S; Galinsky I; DeAngelo DJ; Clark JJ; Lee SJ; Golub TR; Wadleigh M; Gilliland DG; Levine RL
PLoS Med; 2006 Jul; 3(7):e270. PubMed ID: 16834459
[TBL] [Abstract][Full Text] [Related]
37. A Comprehensive Update on Molecular and Cytogenetic Abnormalities in T-cell Prolymphocytic Leukemia (T-pll).
Delgado P; Starshak P; Rao N; Tirado CA
J Assoc Genet Technol; 2012; 38(4):193-8. PubMed ID: 23183331
[TBL] [Abstract][Full Text] [Related]
38. T-Cell Prolymphocytic Leukemia: An Overview of Current and Future Approaches.
Colon Ramos A; Tarekegn K; Aujla A; Garcia de de Jesus K; Gupta S
Cureus; 2021 Feb; 13(2):e13237. PubMed ID: 33728186
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
[TBL] [Abstract][Full Text] [Related]
40. JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors.
Govaerts I; Jacobs K; Vandepoel R; Cools J
Hemasphere; 2019 Dec; 3(6):e313. PubMed ID: 31976485
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
